Fig. 6: Comparison of outcome according to different tools for classification or prognostic evaluation t- versus p-MDS. | Leukemia

Fig. 6: Comparison of outcome according to different tools for classification or prognostic evaluation t- versus p-MDS.

From: Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Fig. 6

a Comparison p- and t-MDS according to WHO-classification. b Comparison t- and p-MDS according to IPSS-R risk-categories. c Comparison t- and p-MDS according to cytogenetic IPSS-R categories.

Back to article page